The ‘Global Emergency’ of Tuberculosis

Ryan F . Tuberculosis: the greatest story never told Bromsgrove: Swift, 1992.

Murray CJL Styblo K Rouillon A . Tuberculosis in developing countries: burden, intervention, and cost. Bull Int Union Tuberc Lung Dis 1990; 65(1):6–24.

World Health Organization. TB - a global emergency. Geneva: World Health Organization, 1994. (WHO/TB/94.177)

Thoen CO Steele JH (eds).Mycobacterium bovis infection in humans and animals Ames, Iowa: Iowa State University Press, 1995.

World Health Organization. The world health report 1998. Geneva: World Health Organization, 1998.

World Health Organization. Global tuberculosis control. WHO report 1997. Geneva: World Health Organization Global Tuberculosis Programme, 1997. (WHO/TB/97.225).

Dolin PJ Raviglione MC Kochi A . Global tuberculosis incidence and mortality during 1990–2000. Bull Wld Hlth Org 1994; 72:213–20.

Chretien J . Tuberculosis and HIV. The cursed duet. Bull Int Union Tuberc Lung Dis 1990; 65(1):25–8.

World Health Organization. Tuberculosis in the era of HIV. A deadly partnership. Geneva: World Health Organization, 1996. (WHO/TB/ 96.204)

UNAIDS/WHO. Fact sheet: Report on the global HIV/AIDS epidemic, December 1997. Geneva: World Health Organization. November 26th1997.

Chintu C Zumla A . Childhood tuberculosis and infection with the Human Immunodeficiency Virus. J R Coll Phys Lond 1995; 29:92–4.

Schulzer M Fitzgerald JM Enarson DA Grzybowski S . An estimate of the future size of the tuberculosis problem in sub Saharan Africa resulting from HIV infection. Tubercle Lung Dis 1992; 73:52–8.

Festenstein F Grange JM . Tuberculosis and the acquired immune deficiency syndrome. J Appl Bacteriol 1991; 71:19–30.

Huebner RE Castro KG . The changing face of tuberculosis. Ann Rev Med 1995; 46:47–55.

Daley CL . The typically ‘atypical’ radiographic presentation of tuberculosis in advanced HIV disease. Tubercle Lung Dis 1995; 76:475–6.

Elliott AM Foster SD . Thiacetazone: time to call a halt? Tubercle Lung Dis 1996; 77:27–9.

Centers for Disease Control. The 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid Mortal Wkly Rep 1993; 41–17:1–19.

Davies PDO (ed.). Clinical tuberculosis. 2nd. edn London: Chapman and Hall, 1998.

Crofton J Horne N Miller F . Clinical tuberculosis London: Macmillan, 1992.

Stegen G Jones K Kaplan P . Criteria for guidance in the diagnosis of tuberculosis. Pediatrics 1969; 43:260–3.

Tshibwabwa-Tumba E Mwinga A Pobee JOM Zumla A . Radiological features of pulmonary tuberculosis in 963 HIV infected adults at three central African hospitals. Clin Radiol 1997; 52:837–41.

World Health Organization. Treatment of tuberculosis. Guidelines for national programmes. Second edition. Geneva: World Health Organization, 1997. (Available from the WHO Website: http:/www.who.ch/gtb)

Nolan CM . Nosocomial multidrug-resistant tuberculosis - global spread of the third epidemic. J Infect Dis 1997; 76:748–51.

Farmer P Kim JY . Community based approaches to the control of multidrug resistant tuberculopsis: introducing ‘DOTS-plus’. BMJ 1998; 317:671–4.

World Health Organization. Anti-tuberculosis drug resistance in the world. The WHO/IUATLD global project on anti tuberculosis drug resistance surveillance. Geneva: World Health Organization, 1997.

Meek J . Killer TB threat to world. Guardian Sept 23, 1998:15.

World Health Organization. Guidelines for the management of drug-resistant tuberculosis. Geneva: World Health Organization, 1997.

Protocol for the implementation of Individualized Treatment Regimens (ITR) for MDRTB in resource-poor settings Boston: Harvard Medical School. Program for Infectious Disease and Social Change, 1998.

Young DB . Blueprint of the white plague. Nature 1998; 393:537–44.

Department of Health. Immunisation against infectious disease, 1996 edition. London: HMSO, 1996;219–41.

Fine PEM . Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995; 346:1339–45.

Collins CH Grange JM Yates MD . Mycobacteria in water. J Appl Bacteriol 1984; 57:193–211.

Bothamley GH Grange JM . The Koch phenomenon and delayed hypersensitivity 1891 - 1991. Tubercle 1991; 72:7–12.

von Pirquet C . Demonstration zur Tuberculindiagnose durch Hautimpfung. Berl Klin Wschr 1907; 48:699.

Rich AR McCordock HA . Enquiry concerning the role of allergy, immunity and other factors of importance in the pathogenesis of human tuberculosis. Bull Johns Hopkins Hosp 1929; 44:273–422.

Hernandez-Pando R Rook GAW . The role of TNFa in T cell-mediated inflammation depends on the Th1/Th2 cytokine balance. Immunology 1994; 82:591–5.

Bretscher PA . A strategy to improve the efficacy of vaccination against tuberculosis and leprosy. Immunol Today 1991; 13:342–5.

Baker RW Zumla A Rook GAW . Tuberculosis, steroid metabolism and immunity. QJ Med 1996; 89:387–94.

Rook GAW Steele J Ainsworth M Leveton CA . A direct effect of glucocorticoid hormones on the ability of human and murine macrophages to control the growth of M. tuberculosis. Eur J Resp Dis 1987; 71:286–91.

Lerner BH . Can stress cause disease? Revisiting the tuberculosis research of Thomas Holmes, 1949–1961. Ann Intern Med 1996; 124:673–80.

Romanus V . Swedish experiences 12 years after the cessation of general BCG vaccination of new borns in 1975. Bull Int Union Tuberc Lung Dis 1988; 63(4):34–8.

Grange JM . Complications of bacille Calmette-Guérin (BCG) vaccination and immunotherapy and their management. Commun Dis Publ Hlth 1998; 1:84–8.

Grange JM . Vaccination against tuberculosis: past problems and future hopes. Semin Respir Crit Care Med 1997; 18:459–70.

Dove A . US panel recommends major tuberculosis vaccine effort. Nat Med 1998; 4:1097.

World Health Organization. Summary, conclusions and recommendations from the tuberculosis workshop on ‘Research towards global control and prevention of tuberculosis: with an emphasis on vaccine development’. J Infect Dis 1988; 158:248–53.

Collins CH Grange JM Yates MD . Tuberculosis bacteriology. Organization and practice. 2nd edn Oxford: Butterworth Heinemann, 1997.

Heifets L . Rapid automated methods (BACTEC system) in clinical mycobacteriology. Semin Respir Infect 1986; 1:242–9.

Butcher PD Hutchinson NA Doran TJ Dale JW . The application of molecular techniques to the diagnosis and epidemiology of mycobacterial diseases. J Appl Bacteriol 1996; 81(suppl):53S-71S.

Vuorinen P Miettinen A Vuento R Hällström O . Direct detection of Mycobacterium tuberculosis complex in respiratory specimens by Gen-Probe Mycobacterium Tuberculosis Direct Test and Roche Amplicor Mycobacterium Tuberculosis Test. J Clin Microbiol 1995; 33:1856–9.

Grange JM Zumla A . Anti-tuberculosis agents. In: Armstrong D Cohen J . Infectious diseases London: Mosby International,, 1999; (in press).

Drobniewski FA Wilson SM . The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis - a molecular story. J Med Microbiol 1998; 47:189–96.

van Embden JDA Cave MD Crawford JT . Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardised methodology. J Clin Microbiol 1993; 31:406–9.

Hayward AC Watson JM . Typing of mycobacteria using spoligotyping. Thorax 1998; 53:329–30.

Sumartojo E . When tuberculosis treatment fails. A social behavioural account of patient adherence. Amer Rev Respir Dis 1993; 147:1311–20.

Coker R Miller R . HIV associated tuberculosis. BMJ 1997; 314:1847.

Fox R . Are you a commander or a guide? J R Soc Med 1997; 90:242–3.

Stephens C . The owl and the pussycat went to sea: moving towards intersectorial policies to prevent the unequal distribution of tuberculosis. In: Porter JDH Grange JM (eds). Tuberculosis - an interdisciplinary perspective London: Imperial College Press,, 1999; (in press).

Stanford JL Stanford CA . Immunotherapy for tuberculosis with M. vaccae. J Med Microbiol 1996; 44:24–34.

Holme CI . Trial by TB. Proc R Coll Physicians Edinb 1997; 27(Suppl 4):1–54.